Sarmiento Palma Julieth Vivian, Sambracos Parrado Santiago, Echeverria Maria Camila, Ruiz Talero Paula
Pontificia Universidad Javeriana, School of Medicine, Bogotá, Colombia.
Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá, Colombia.
Clin Med Insights Case Rep. 2024 May 15;17:11795476241253106. doi: 10.1177/11795476241253106. eCollection 2024.
We report the case of a 27-year-old man with transthyretin amyloidosis secondary to the p.Val142Ile mutation with an atypical clinical presentation of predominantly lower limb polyneuropathy without cardiac involvement. p.Val142Ile is mainly associated with cardiopathy, whereas the neuropathic phenotype is mainly associated with p.Val50Met. Our patient belongs to a non-endemic region and due to his lack of support network a possible familial component is unknown. His case represents a diagnostic challenge given the wide heterogeneity of clinical manifestations associated with the disease, with other possible diagnoses of polyneuropathy being reasonably excluded according to prevalence and frequency. The particularly unusual genotype-phenotype association distinguishes this case from the classic description of transthyretin amyloidosis secondary to p.Val142Ile.
我们报告了一例27岁男性,患有因p.Val142Ile突变导致的转甲状腺素蛋白淀粉样变性,临床表现不典型,主要为下肢多发性神经病,无心脏受累。p.Val142Ile主要与心脏病相关,而神经病变表型主要与p.Val50Met相关。我们的患者来自非流行地区,由于缺乏支持网络,家族性因素未知。鉴于该疾病临床表现的广泛异质性,他的病例具有诊断挑战性,根据患病率和发病率合理排除了其他可能的多发性神经病诊断。这种特别不寻常的基因型-表型关联使该病例有别于继发于p.Val142Ile的转甲状腺素蛋白淀粉样变性的经典描述。